Jiangxi Institute of Biological Products Inc. Class H 6915

HKEX · Hong Kong SAR China · Health Technology

HKD 11.30+0.73 (+6.91%)

Market closed· Oct 2, 2026, 8:08 AM UTC· HKD · Data may be delayed

Company news

Yahoo FinanceJul 27, 2026

Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio

Jiangxi Institute of Biological Products Inc. and its subsidiaries (collectively, "Jiangxi Bio" or the "Group") (stock code: 6915.HK) is pleased to announce that the veterinary tetanus antitoxin ("Veterinary TAT") production line of Chifeng Bo-en Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the Group, officially commenced production on July 20, 2026 in Chifeng City, Inner Mongolia Autonomous Region.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.